GlassScriptPhysician profile
Fremont L Scott
NPI 1932172855
$5,700.81
in general payments reported to CMS, 2019-2025
16 companies · $1,019 in 2025
The $1,019 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $284 · 2021: $1,677 · 2022: $749 · 2023: $594 · 2024: $911 · 2025: $1,019.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,523.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $1,337.34 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $1,306.77 | 2021-2025 | Persona, Juggerknotless Soft Anchor, Oxford |
| Stryker Corporation | $1,113.50 | 2020-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Aequalis Perform |
| Avanos Medical | $422.45 | 2019-2025 | On-Q Pump and Accessories |
| Kci USA, INC. | $191.17 | 2022-2023 | V.A.C. Veraflo |
| Depuy Synthes Sales INC. | $175.91 | 2019-2020 | |
| Smith+Nephew, INC. | $167.56 | 2022 | |
| Bone Support INC. | $156.42 | 2024 | Ceramentbone Void Filler, Cerament G |
| Catalyst Orthoscience | $146.38 | 2025 | |
| Si-Bone, INC. | $134.44 | 2024 | |
| Heron Therapeutics, INC. | $121.35 | 2024 | Zynrelef |
| Davol INC. | $119.48 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $117.88 | 2025 | Exparel |
| Pacira Therapeutics, INC. | $102.51 | 2019 | |
| Ethicon US, LLC | $58.03 | 2025 | Ethicon, Stratafix, Surgiflo Hemostatic Matrix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $29.62 | 2023 | Dalvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fremont Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.